Use of Clindamycin in Pediatric Infections

Marcia L. Buck, Pharm.D., FCCP


Pediatr Pharm. 2008;14(2) 

In This Article


lindamycin is a semisynthetic derivative of lincomycin developed in the mid1960’s. Since its introduction, it has become a standard therapy for the treatment of anaerobic infections and is often used to treat Gram positive infections in patients allergic to betalactam antibiotics.[1] More recently, clindamycin has become an important component in the treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections. This issue of Pediatric Pharmacotherapy will provide a basic review of the pharmacology of clindamycin and highlight several new papers describing its use in treating pediatric infections.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.